The Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa Interventions: Drug: OCU400 Low Dose; Drug: OCU400 Mid Dose; Drug: OCU400 High Dose Sponsor: Ocugen Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials